Whether you are managing metabolic syndrome or simply looking to enhance your body's internal balance, our clinical grade berberine provides the comprehensive systemic support your endocrine system demands
Go directly to the ER
Based on the Phase 2 trial trajectory, users may expect an additional 1-2 kg of fat loss beyond what caloric deficit alone would produce during this period
MAXIMUM NUTRITION: 25g of protein, 2g sugar, 3g carbs, 120 calories, and 5.9g BCAAs per serving
Following administration in animal models: BPC-157 demonstrates rapid systemic distribution within 15-30 minutes with unusual oral bioavailability TB-500 shows tissue-specific accumulation with preferential uptake in injured areas GHK-Cu exhibits copper-mediated transport and gene-modulating tissue binding KPV utilizes PepT1 transporter-mediated uptake with enhanced delivery to inflamed tissues Combined formulation provides immediate, sustained, and targeted bioactivity across multiple mechanisms Distribution studies suggest that injury sites and inflamed tissues tend to concentrate multiple components through different mechanisms BPC-157 through injury-site targeting, TB-500 through actin-rich repair zones, GHK-Cu through copper-dependent pathways, and KPV through upregulated PepT1 in inflammation, potentially enhancing local therapeutic effects
Rapid weight loss raises gallstone risk regardless of which compounds drive the loss
